A PHASE 1 OPEN-LABEL CROSSOVER STUDY TO EVALUATE BIOEQUIVALENCE OF ORAL SUSPENSION AND TABLET FORMULATIONS OF PERAMPANEL IN HEALTHY SUBJECTS

被引:0
|
作者
Laurenza, A. [1 ]
Hall, N. [1 ]
Majid, O. [2 ]
Rege, B. [1 ]
机构
[1] Eisai Inc, Woodcliff Lake, NJ USA
[2] Eisai Ltd, Hatfield, Herts, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P561
引用
收藏
页码:170 / 171
页数:2
相关论文
共 50 条
  • [1] Bioequivalence evaluation of perampanel oral suspension and tablet formulations in healthy subjects: a Phase I, open-label, crossover study
    Laurenza, Antonio
    Hall, Nancy
    Majid, Oneeb
    Rege, Bhaskar
    NEUROLOGY, 2017, 88
  • [2] Pharmacokinetic bioequivalence of sitagliptin phosphate tablet formulations: a randomized, open-label, crossover study in healthy volunteers
    Leong, Chuei Wuei
    Sagim, Elton
    Yee, Kar Ming
    Saharuddin, Muhammad Shalhadi
    Abdullah, Nik Mohd Zulhakimi Nik
    Saberi, Noramirah Farhanah
    Boopathy, Rajavikraman
    Ahmad, Shahnun
    Amran, Atiqah
    Batheja, Raman
    Sharma, Rajan
    Vuppalavanchu, Kiran Kumar
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2023, 12 (01):
  • [3] Levocetirizine Oral Disintegrating Tablet: A Randomized Open-Label Crossover Bioequivalence Study in Healthy Japanese Volunteers
    Ino, Hiroko
    Shiramoto, Masanari
    Eto, Takashi
    Haranaka, Miwa
    Irie, Shin
    Terao, Takumi
    Ogura, Hirofumi
    Wakamatsu, Akira
    Hoyano, Keiko
    Nakano, Atsushi
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (07): : 805 - 812
  • [4] A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension
    Li, Yan
    Liu, Liangang
    Huang, Lian
    Wang, Xiaomin
    Hoffmann, Matthew
    Reyes, Josephine
    Palmisano, Maria
    Zhou, Simon
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 1089 - 1099
  • [5] Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial
    Ascaso-del-Rio, Ana
    Camargo-Mamani, Paola
    Gilaberte, Inmaculada
    Diez-Hochleitner, Monica
    Laredo-Velasco, Leonor
    Iglesias-Hernangomez, Teresa
    Salas-Butron, Maria Rosario
    Caballero, Laura Galan
    Diaz-Rengifo, Ivan Alejandro
    Perez-Ingidua, Carla
    Vargas-Castrillon, Emilio
    Portoles-Perez, Antonio
    PHARMACEUTICALS, 2025, 18 (03)
  • [6] A randomized, open-label, crossover study evaluating bioequivalence of two N-acetylcysteine 2% oral solution formulations in healthy subjects
    Donath, Frank
    Armogida, Marianna
    Shneyer, Lucy
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (09) : 417 - 425
  • [7] A Phase 1 Study to Evaluate the Bioequivalence of Oral Tablet and Orally Dissolving Tablet Formulations of Rimegepant in Healthy Adult Subjects Under Fasting Conditions
    Croop, R.
    Ivans, A.
    Stock, D.
    Hould, J.
    Morris, B. A.
    Stringfellow, J.
    Moulin, J.
    Larouche, R.
    Tanguay, M.
    Coric, V
    Lipton, R. B.
    HEADACHE, 2018, 58 (08): : 1303 - 1304
  • [8] A Phase 1, Open-label, Crossover Study To Evaluate The Bioequivalence Of Intramuscular And Subcutaneous Peginterferon Beta-1a In Healthy Volunteers
    Zhao, Y.
    Chen, K.
    Ramia, N.
    Sahu, S.
    Kumar, A.
    Naylor, M. L.
    Zhu, L.
    Butts, C.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 37 - 38
  • [9] Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open-Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers
    Leong, Chuei Wuei
    Yee, Kar Ming
    Liew, Ivan
    Khaleb, Nur Athirah
    Ahmad, Shahnun
    Rani, Tracy Ann
    Lau, Kheng Jim
    Yunaidi, Danang Agung
    Simanjuntak, Ronal
    Ginanjar, Vicky A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (08): : 890 - 896
  • [10] Pharmacokinetics and Bioequivalence of 2 Azithromycin Tablet Formulations: A Randomized, Open-Label, 2-Stage Crossover Study in Healthy Volunteers
    Leong, Chuei Wuei
    Yee, Kar Ming
    Nalaiya, Jeyashanthini
    Kassim, Zawahil
    Rahim, Sharifah Radziah Syed Abd
    Ahmad, Shahnun
    Amran, Atiqah
    Krishnamurthy, Lakshman
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09): : 1078 - 1083